A detailed history of Clarendon Private LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Clarendon Private LLC holds 10,046 shares of BSX stock, worth $1 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
10,046
Previous 9,009 11.51%
Holding current value
$1 Million
Previous $909 Million 18.73%
% of portfolio
1.04%
Previous 0.96%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 25, 2025

BUY
$89.7 - $107.41 $93,018 - $111,384
1,037 Added 11.51%
10,046 $1.08 Billion
Q1 2025

May 07, 2025

BUY
$89.38 - $106.18 $102,071 - $121,257
1,142 Added 14.52%
9,009 $909 Million
Q4 2024

Jan 21, 2025

BUY
$83.62 - $91.5 $657,838 - $719,830
7,867 New
7,867 $703 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $143B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Clarendon Private LLC Portfolio

Follow Clarendon Private LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarendon Private LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarendon Private LLC with notifications on news.